Rubella antibody screening during pregnancy in an urban area of Northern Italy

Infectious Disease Reports

Volumn 4, Issue 1, 2012, Pages 59-62

  De Paschale, Massimo ^a   Manco, Maria Teresa ^a   Paganini, Alessia ^a   Agrappi, Carlo ^a   Mirri, Paola ^a   Cucchi, Gabriella ^a   Saccani, Barbara ^a   D'Arcais, Alberto Flores ^a   Clerici, Pierangelo ^a  

^a Hospital of Legnano   (Italy)

Author keywords

Antibodies; Pregnancy; Rubella; Screening; Vaccination

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; RUBELLA ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; DISEASE PREDISPOSITION; EASTERN EUROPE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; ITALY; PREGNANCY; RUBELLA; SEROPREVALENCE; SOUTH AND CENTRAL AMERICA; URBAN POPULATION;

EID: 84866790549     PISSN: None     EISSN: 20367449     Source Type: Journal    
DOI: 10.4081/idr.2012.e17     Document Type: Article

References (35)

1. Mellinger AK, Cragan JD, Atkinson WL, et al. High incidence of congenital rubella syndrome after a rubella outbreak. Pediatr Infect Dis J 1995;14:573-8.
2. Cooper LZ, Altford CA, Rubella. In: Remington JS, Klein JO, Baker C, Wilson C, editors. Infectious diseases of the fetus and newborn infant. Philadelfia: Elsevier Saunders; 2006. p.893-926.
3. World Health Organization. Report of a meeting on preventing congenital rubella syndrome: immunization strategies, surveillance needs, Geneva, 12-14 January 2000. Geneva, World Health Organization, 2000. Available from: https://extranet.who.int/ivb_docs/documents/1928
4. Anderson RM, May RM. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg 1983;90:259-325.
5. WHO. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec 2011;86:301-16.
6. European Health for All Series. Health21: The health for all policy framework for the WHO European Region 1999;6:49.
7. World Health Organization. Eliminating measles and rubella and preventing congenital rubella infection. WHO European Region strategic plan 2005-2010. Copenhagen, Denmark: WHO Regional Office for Europe, 2005.
8. Salmaso S, Rota MC, Ciofi degli Atti ML, et al. Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. Bull World Health Organ 1999;77:843-51.
9. Ciofi degli Atti ML, Rota MC, Bella A, et al. Do changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in Italy. Vaccine 2004;22:4351-7.
10. Gabutti G, Rota MC, Salmaso S, et al. Epidemiology of measles, mumps and rubella in Italy. Epidemiol Infect 2002;129:543-50.
11. Rota MC, Bella A, Gabutti G, et al. Rubella seroprofile of the Italian population: an 8- year comparison. Epidemiol Infect 2007; 135:555-62.
12. Pebody RG, Edmunds WJ, Conyn van Spaendonck M, et al. The seroepidemilogy of rubella in Western Europe. Epidemiol Infect 2000;125:347-57.
13. Eggers M, Enders M, Strobel S, et al. A novel and rapid method for determination of rubella virus immunoglobulin G avidity. Clin Microbiol Infect 2005;11Suppl2:33.
14. Giambi C, Rota MC, Bella A, et al. Rubella epidemiology in Italy in the years 1998-2004. Ann Ig 2007;19:93-102.
15. Lo Giudice D, Cannavò G, Capua A, et al. Eliminating congenital rubella: a seroepidemiological study on women of childbearing age and MMR vaccine coverage in newborns. J Prev Med Hyg 2009;50:236-40.
16. Gonçalves G, Nascimento MS, Réu C, Cutts FT. Levels of rubella antibody among vaccinated and unvaccinated Portuguese mothers and their newborns. Vaccine 2006;24: 7142-7.
17. Dominguez A, Plans P, Espunes J, et al. Rubella immune status of indigenous and immigrant pregnant women in Catalonia, Spain. Europ J Public Health 2007;17:560-4.
18. Kakoulidou M, Forsgren M, Lewensohn- Fuchs I, Johansen K. Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes. Vaccine 2010;28:1002-7.
19. Davidkin I, Peltola H, Leinikki P, Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine 2000;18:3106-12.
20. Kremer JR, Schneider F, Muller CP. Waning antibodies in measles and rubella accinees-a longitudinal study. Vaccine 2006;24:2594-601.
21. O'Shea S, Woodward S, Best JM, et al. Rubella vaccination: persistence of antibodies for 10-21 years. Lancet 1988;2:909.
22. King JC, Lichenstein R, Feigelman S, et al. Measles, mumps, and rubella antibodies in vaccinated Baltimore children. Am J Dis Child 1993;147:558-60.
23. Christenson B, Böttiger M. Long-term follow- up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine 1994;12:41-5.
24. Davidkin I, Jokinen S, Broman M, et al. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 2008;197:950-6.
25. Skendzel LP. Rubella immunity: defining the level of protective antibody. Am J Clin Pathol 1996;106:170-4.
26. Matter L, Kogelschatz K, Germann D. Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undertectable antibody concentrations. J Infect Dis 1997;175:749-55.
27. World Health Organization. Strategic plan for measles and congenital rubella infection in the European Region of WHO. Copenhagen, Denmark: WHO Regional Office for Europe, 2003. Available from: http://www.euro.who.int/en/what-we-do/health-topics/communicable-diseases/measles-and-rubella/publications/pre-2009/strategic-plan-for-measles-and-congenitalrubella-infection-in-the-european-regionof-who
28. Lever AM, Ross MG, Baboonian C, Griffiths PD. Immunity to rubella among women of child-bearing age. Br J Obstet Gynaecol 1987;94:208-12.
29. Caritas-Migrantes Foundation. Immigrazione. Dossier Statistico 2008. XVIII Rapporto. Rome: Edizioni Idos, 2008.
30. Tipples GA, Hamkar R, Mohktari-Azad T, et al. Evaluation of rubella IgM enzyme immunoassays. J Clin Virol 2004;30:233-8.
31. Banatvala JE, Best JM, O'Shea S, Dudgeon JA. Persistence of rubella antibodies after vaccination: detection after experimental challenge. Rev Infect Dis 1985;7(suppl 1): S86-90.
32. Best JM, Banatvala JE, Morgan-Capner P, Miller E. Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ 1989;299:773-5.
33. Hedman K, Seppälä I. Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin Immunol 1988;8:214-21.
34. Enders G, Knotek F. Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 1989;17:218-26.
35. Böttiger B, Jensen IP. Maturation of rubella IgG avidity over time after acute rubella infection. Clin Diagn Virol 1997;8:105-11.